
ESMO 2018: One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
Nearly one in six premenopausal women being treated for early stage breast cancer do not…
Nearly one in six premenopausal women being treated for early stage breast cancer do not…
Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase…
Women who have undergone hormonal therapy for breast cancer are at increased risk of developing…